We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

bioMérieux

Designs, develops, manufactures and markets in vitro diagnostics systems used in clinical and industrial applications read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

BioMérieux Acquires Antibiotic Susceptibility Test Firm Specific Diagnostics

By LabMedica International staff writers
Posted on 13 Apr 2022
Print article
Image: bioMérieux has entered into an agreement to acquire Specific Diagnostics (Photo courtesy of Pexels)
Image: bioMérieux has entered into an agreement to acquire Specific Diagnostics (Photo courtesy of Pexels)

Antimicrobial Resistance (AMR) is a global threat, with infections from antibiotic resistant pathogens being one of the leading causes of death around the world. For clinicians to save patients’ lives and rapidly optimize therapies, fast and accurate antimicrobial susceptibility test (AST) results and interpretation are critical. In addition to improving patient outcomes, rapid AST also reduces global AMR burdens by enabling the implementation of effective institutional Antimicrobial Stewardship (AMS) programs.

bioMérieux (Marcy-l'Étoile, France) has further strengthened its commitment to fight AMR with the acquisition of Specific Diagnostics (San Jose, CA, USA) which focuses on fast AST solution. Specific has developed a rapid AST system that delivers phenotypic AST directly from positive blood cultures. The SPECIFIC REVEAL Rapid AST system has been developed based on the company’s unique, patented metabolomic signature technology and offers an easy-to-use instrument with a targeted menu, small footprint, and modular design for adaptable throughput, well-suited to address the needs of clinical laboratories.

The SPECIFIC REVEAL Rapid AST system provides actionable results for Gram-negative bacteria directly from positive blood cultures in an average of five hours. This helps clinicians to address the challenge of bloodstream infections, allowing either timely de-escalation to a focused, more appropriate, and lower-cost therapy, or life-saving rapid escalation to more effective therapy where a multidrug-resistant (MDR) infection is present. SPECIFIC REVEAL seamlessly integrates with bioMérieux’s Sepsis Solution, including BACT/ALERT VIRTUO, VITEK MS PRIME, BIOFIRE BCID2, VIDAS PCT and VITEK2. With the addition of SPECIFIC REVEAL Rapid AST, the bioMérieux Sepsis Solution allows same-day AST results for Gram-negative bacteria to enable more targeted therapy and improve patient outcomes.

“This acquisition reinforces our long-standing commitment to sustain antibiotic efficacy for future generations,” said Alexandre Mérieux, Chairman and Chief Executive Officer, bioMérieux. “With the addition of Specific Diagnostics’ REVEAL Rapid AST system into our microbiology portfolio, bioMérieux further supports clinicians and laboratories in further improving patient outcomes and enhancing antimicrobial stewardship, leveraging our extensive distribution network.”

Related Links:
bioMérieux 
Specific Diagnostics

Gold Supplier
Renin Control
Lumipulse Renin Control
New
Allergen-Specific IgG/IgG4 Enzymimmunoassay
ALLERgen Specific IgG/IgG4 ELISA Kits
New
Anti-HIV 1/2 ELISA Test
HIV 1/2 Antibody (3rd) Test Kit (ELISA)
New
STI Test
Rheonix STI TriPlex Assay

Print article
IIR Middle East

Channels

Technology

view channel
Image: OneDraw Blood Collection Device significantly reduces obstacles for drawing blood (Photo courtesy of Drawbridge Health)

Near Pain-Free Blood Collection Technology Enables High-Quality Testing

Blood tests help doctors diagnose diseases and conditions such as cancer, diabetes, anemia, and coronary heart disease, as well as evaluate organ functionality. They can also be used to identify disease... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.